ActivBiotics Assignee Issues First Distribution of Cash to Creditors

WELLESLEY HILLS, Mass., June 19 Joseph F. Finn, Jr.,C.P.A. ("Finn") the Assignee for the Benefit of Creditors of ActivBiotics,Inc. ("ActivBiotics") announced today the first distribution of cash to thecreditors of ActivBiotics. The distribution signifies the substantialcompletion of the asset liquidation process and the allowance of creditors'claims. The assignment, which began the liquidation process, was a transferof all the assets of ActivBiotics to Finn on December 7, 2007, under a commonlaw procedure. The process was complex because ActivBiotics was a biotechstart-up company with sophisticated intellectual property and fixed assets.

Finn pointed out that the assignment process allowed him to move quicklyand that the distribution of cash to creditors six and a half months after theprocess began highlights one of the major benefits of the assignment legalprocess for liquidating defunct enterprises.

Finn praised the law firm he retained to assist him, Bingham McCutchenLLP, to include, but not be limited to, Edwin Smith, Meerie Joung and JenniferCleary.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr. is the founding partner of the firm Finn, Warnke &Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. Heworks primarily in the area of management consulting for distressedenterprises, bankruptcy accounting and related matters, such as assignee forthe benefit of creditors and liquidating agent for a corporation. He has beeninvolved in a number of loan workouts and bankruptcy cases for thirty-four(34) years.

SOURCE ActivBiotics, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...